Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

S7504

Sigma-Aldrich

Salicylhydroxamic acid

Synonym(s):

2-Hydroxybenzohydroxamic acid, N,2-Dihydroxybenzamide

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
HOC6H4CONHOH
CAS Number:
Molecular Weight:
153.14
EC Number:
MDL number:
UNSPSC Code:
12352100

mp

177 °C (dec.) (lit.)

SMILES string

ONC(=O)c1ccccc1O

InChI

1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)

InChI key

HBROZNQEVUILML-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

replaced by

Product No.
Description
Pricing

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Prasenjit Mukherjee et al.
Bioorganic & medicinal chemistry, 16(9), 5254-5265 (2008-03-26)
The histone deacetylase (HDAC) enzyme from Plasmodium falciparum has been identified as a novel target for the development of antimalarial therapy. A ligand-refined homology model of PfHDAC-1 was generated from the crystal structures of human HDAC8 and HDLP using a
Benoît M R Liénard et al.
Bioorganic & medicinal chemistry letters, 17(4), 964-968 (2006-12-13)
Metallo-beta-lactamases (MBLs) catalyze the hydrolysis of beta-lactams including penicillins, cephalosporins and carbapenems. Starting from benzohydroxamic acid (1) structure-activity studies led to the identification of selective inhibitors of the FEZ-1 MBL, e.g., 2,5-substituted benzophenone hydroxamic acid 17 has a K(i) of
Charlotte A Lanteri et al.
Antimicrobial agents and chemotherapy, 52(3), 875-882 (2007-12-19)
Human African trypanosomiasis (HAT) is a fatal tropical disease caused by infection with protozoans of the species Trypanosoma brucei gambiense and T. b. rhodesiense. An oral prodrug, DB289, is a promising new therapy undergoing phase III clinical trials for early-stage
David J Merkler et al.
Bioorganic & medicinal chemistry, 16(23), 10061-10074 (2008-10-28)
Peptidyl alpha-hydroxylating monooxygenase (PHM) functions in vivo towards the biosynthesis of alpha-amidated peptide hormones in mammals and insects. PHM is a potential target for the development of inhibitors as drugs for the treatment of human disease and as insecticides for

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service